Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb" ALT"This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb"August 4, 2017By Mark Terry,…

Continue ReadingThis Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb

Dynavax Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-dynavax.jpg" NAME"Dynavax Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav" ALT"Dynavax Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav"August 4, 2017By Mark Terry,…

Continue ReadingDynavax Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav